Effect of nano-curcumin supplementation on liver fibrosis in patients with NAFLD-associated fibrosis: a double-blind randomized controlled trial.

Sci Rep · 2025 · PMC12575708 · PMID 41168313

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0540

boldest claim

The sentences

approaching significanceP = 0.05actually significant

Similarly, AST levels were higher in the nanocurcumin group (38.44 ± 23.38 U/L) compared to the placebo group (27.21 ± 10.07 U/L), with a P -value approaching significance ( P = 0.05).

also in 2,640 other papers

did not reach statistical significanceP = 0.054so close (0.05 < p ≤ 0.1)

Within-group reductions did not reach statistical significance in either group ( P = 0.054 for nanocurcumin, P = 0.547 for placebo).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.